Page History
Anchor | ||||
---|---|---|---|---|
|
Info |
---|
The system will not display this section if you indicated that you do not require an XML document for ClinicalTrials.gov. |
HTML Comment | ||
---|---|---|
| ||
Screenshot TBD. |
How to Complete the Regulatory Information Section
Select or enter the appropriate information in the text fields and drop-down lists. The following table describes the fields. An asterisk (*) indicates a required field. For a definition of each field. See the ClinicalTrials.gov Protocol Data Element Definitions for definitions for these fields, refer to http://prsinfo.clinicaltrials.gov/definitions.html.
Instructions for recording regulatory information
Field Label | Description/Instructions | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
FDA Regulated Intervention Indicator* | Indicate whether the trial is regulated by the FDA by selecting Yes or No.
| |||||||||||
Section 801 Indicator* | For interventional trials, indicate whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801 by selecting Yes or No.
| |||||||||||
Delayed Posting Indicator* | This indicator becomes available only when you indicate that the trial is applicable under Section 801. Only the CTRO can modify this indicator’s value:
To change this indicator’s value, submit a request to the CTRO at ncictro@mail.nih.gov. | |||||||||||
Studies a U.S. FDA-regulated Drug Product |
| |||||||||||
Studies a U.S. FDA-regulated Device Product |
| |||||||||||
Unapproved/Uncleared Device |
| |||||||||||
Pediatric Post-market Surveillance |
| |||||||||||
Product Exported from the U.S. |
| |||||||||||
FDA Regulated Intervention Indicator |
| |||||||||||
Section 801 Indicator |
| |||||||||||
Data Monitoring Committee Appointed Indicator |
| Data Monitoring Committee Appointed Indicator | Optionally, indicate whether a data monitoring committee has been appointed for this trial by selecting Yes or No. Info | |